|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2004-8-10
|
|
pubmed:abstractText |
Preexisting osteopenia and osteoporosis in men with prostate cancer are of concern due to accelerated bone loss during androgen deprivation therapy (ADT). We sought to identify risk factors for osteoporosis in men with prostate cancer who have not received ADT to help determine which patients may need bone mineral density (BMD) testing prior to ADT.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1527-9995
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
64
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
335-40
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15302490-Absorptiometry, Photon,
pubmed-meshheading:15302490-Adenocarcinoma,
pubmed-meshheading:15302490-Adult,
pubmed-meshheading:15302490-Age Factors,
pubmed-meshheading:15302490-Aged,
pubmed-meshheading:15302490-Alcohol Drinking,
pubmed-meshheading:15302490-Androgen Antagonists,
pubmed-meshheading:15302490-Antineoplastic Agents, Hormonal,
pubmed-meshheading:15302490-Body Mass Index,
pubmed-meshheading:15302490-Bone Density,
pubmed-meshheading:15302490-Bone Diseases, Metabolic,
pubmed-meshheading:15302490-Clinical Trials as Topic,
pubmed-meshheading:15302490-Cohort Studies,
pubmed-meshheading:15302490-Combined Modality Therapy,
pubmed-meshheading:15302490-Comorbidity,
pubmed-meshheading:15302490-Femur Neck,
pubmed-meshheading:15302490-Humans,
pubmed-meshheading:15302490-Life Style,
pubmed-meshheading:15302490-Lumbar Vertebrae,
pubmed-meshheading:15302490-Male,
pubmed-meshheading:15302490-Middle Aged,
pubmed-meshheading:15302490-Neoplasm Proteins,
pubmed-meshheading:15302490-Neoplasm Staging,
pubmed-meshheading:15302490-Obesity,
pubmed-meshheading:15302490-Osteoporosis,
pubmed-meshheading:15302490-Prospective Studies,
pubmed-meshheading:15302490-Prostate-Specific Antigen,
pubmed-meshheading:15302490-Prostatic Neoplasms,
pubmed-meshheading:15302490-Risk Factors,
pubmed-meshheading:15302490-Smoking,
pubmed-meshheading:15302490-Socioeconomic Factors,
pubmed-meshheading:15302490-Thinness,
pubmed-meshheading:15302490-Tumor Markers, Biological
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
|
|
pubmed:affiliation |
Department of Nursing, University of California, Los Angeles, School of Nursing, Los Angeles, California, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
